Ocular Therapeutix Inc (OCUL) stock is higher by 258.44% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives OCUL stock a score of 72 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 79. OCUL's rank also includes a long-term technical score of 73. The fundamental score for OCUL is 63. In addition to the average rating from Wall Street analysts, OCUL stock has a mean target price of 24.6. This means analysts expect the stock to add 24.56% over the next 12 months.
What's Happening with OCUL Stock Today
Ocular Therapeutix Inc (OCUL) stock is higher by 3.19% while the S&P 500 is lower by -0.16% as of 1:16 PM on Thursday, Feb 11. OCUL is higher by $0.61 from the previous closing price of $19.14 on volume of 793,468 shares. Over the past year the S&P 500 is higher by 15.51% while OCUL is higher by 258.44%. OCUL lost -$1.77 per share in the over the last 12 months.